Table 2.

Inclusion and exclusion criteria of multiple experiences with minimally invasive pancreatoduodenectomy

Year	Eligible patients	Exclusion criteria	Procedure	Reference
2010	Benign and malignant disease	Possible venous resection	Laparoscopic PD	(7)
2012	Resectable pancreatic tumors	Medical comorbidities, high risk for non-R0 resection	Robotic PD	(11)
2012	Patient preference for Laparoscopic PD	Major PV resection, “hostile abdomen”	Laparoscopic vs. open PD	(14)
2013	Small periampullary tumors, benign lesion, low grade malignancy	No comorbidities	Laparoscopic PD assisted by mini-laparotomy	(8)
2014	Patients undergoing PD with vascular resection	–	Laparoscopic vs. open PD	(23)
2015	Benign and malignant disease	–	Laparoscopic PD	(12)
2016	Periampullary cancers	Borderline resectable disease, morbid obesity, adhesive disease	Laparoscopic vs. open PD	(6)
2016	Periampullary tumors	SMV/PV or SMA involvement, adjacent organ invasion	Robotic vs. open PD	(18)
2017	Periampullary cancers	Vascular invasion, Neoadjuvant chemotherapy	Laparoscopic vs. open PD	(10)
2018	Periampullary cancers	Vascular invasion, neoadjuvant chemotherapy	Laparoscopic vs. open PD	(19)

PD, pancreaticoduodenectomy; SMV, superior mesenteric vein; PV, portal vein; SMA, superior mesenteric artery.